GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference

Trending Topics in Gastroenterology

Explore current gastroenterology questions, clinical answers, and emerging research by topic.

61

Circulating microbiome profiling in transjugular intrahepatic portosystemic shunt patients: 16S rRNA vs. shotgun sequencing

The study focused on comparing the performance of 16S rRNA sequencing and shotgun metagenomic sequencing for profiling the circulating microbiome in patients undergoing transjugular intrahepatic portosystemic shunt (TIPS)...

62

ACLF—Contrasting Perspectives From the East and West

Acute-on-chronic liver failure (ACLF) is a severe condition characterized by acute decompensation in patients with chronic liver disease, accompanied by organ failures and high short-term mortality. However, the...

63

Management of alcohol use disorder in alcohol-related liver disease

Management of alcohol use disorder (AUD) in alcohol-related liver disease (ArLD) is a critical component of improving patient outcomes and preventing the progression of liver damage. The coexistence...

64

Esophagogastric Variceal Bleeding in Cirrhotic Portal Hypertension

Esophagogastric variceal bleeding (EVB) is a critical and potentially life-threatening complication of cirrhotic portal hypertension, resulting from elevated portal venous pressure due to liver cirrhosis. Understanding the pathophysiology,...

65

Breath Biopsy

Breath Biopsy refers to a cutting-edge, non-invasive diagnostic technique that analyzes volatile organic compounds (VOCs) present in exhaled breath to detect metabolic changes associated with various diseases, including...

66

Bacterial Infections in ACLF

Bacterial infections play a critical role in the development and progression of Acute-on-Chronic Liver Failure (ACLF). They are not only common in ACLF patients but are also a...

67

Enterococcus faecium DNA in acute decompensated cirrhosis

Enterococcus faecium (EF) DNA plays a significant role in acute decompensated liver cirrhosis, particularly in cases of acute-on-chronic liver failure (ACLF). Cirrhosis, a severe liver condition, causes over...

68

Hepatitis B Guidelines- AASLD 2025

The 2025 AASLD/IDSA Practice Guideline on the treatment of chronic hepatitis B was released on November 4, 2025. It includes significant updates compared to the previous guidelines from...

69

Emerging and potential use of CRISPR in human liver disease

CRISPR technology is rapidly emerging as a transformative tool in the study and treatment of human liver diseases. Its versatility and precision have opened up new possibilities for...

70

Mean arterial pressure in patients with cirrhosis and AKI

Mean arterial pressure (MAP) plays a critical role in managing patients with cirrhosis and acute kidney injury (AKI), but its application in this population is nuanced and requires...

Previous
167810
Next
GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersSoonFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer